KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Common Equity (2016 - 2025)

Labcorp Holdings (LH) has disclosed Common Equity for 17 consecutive years, with $8.6 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 7.05% to $8.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.6 billion through Dec 2025, up 7.05% year-over-year, with the annual reading at $8.6 billion for FY2025, 7.05% up from the prior year.
  • Common Equity hit $8.6 billion in Q4 2025 for Labcorp Holdings, down from $8.7 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $10.7 billion in Q1 2022 to a low of $7.9 billion in Q3 2023.
  • Historically, Common Equity has averaged $9.2 billion across 5 years, with a median of $8.7 billion in 2023.
  • Biggest five-year swings in Common Equity: surged 43.85% in 2021 and later fell 23.03% in 2024.
  • Year by year, Common Equity stood at $10.3 billion in 2021, then fell by 1.72% to $10.1 billion in 2022, then fell by 22.0% to $7.9 billion in 2023, then grew by 2.25% to $8.1 billion in 2024, then grew by 7.05% to $8.6 billion in 2025.
  • Business Quant data shows Common Equity for LH at $8.6 billion in Q4 2025, $8.7 billion in Q3 2025, and $8.5 billion in Q2 2025.